Clinical Trials Browser

OTHER × Thymoma × Clear all

NCT03463460 2026-03-23

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Phase 2 Active not recruiting

Thymoma

NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT07132918 2026-03-11

HEARTS Trial for Thoracic Cancers

Phase 2 Recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Thymoma

NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Phase 2/3 Not yet recruiting

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

NCT03968315 2026-03-09

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Phase NA Active not recruiting

Thymoma

NCT04710628 2026-02-19

PECATI

Phase 2 Completed

Thymoma

NCT07328074 2026-02-05

Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis

Not yet recruiting

Thymic epithelial tumor, Thymoma

NCT03295227 2026-01-30

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Phase 1 Recruiting

Thymoma

NCT06248515 2026-01-27

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Phase 2 Recruiting

Thymoma

NCT01025089 2026-01-07

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Phase 2 Active not recruiting

Thymoma

NCT01385722 2025-12-26

Molecular Analysis of Thoracic Malignancies

Enrolling by invitation

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms

NCT06838910 2025-12-01

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

Phase 2 Recruiting

Thymoma

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT07179341 2025-09-17

Survival Nomogram for Patients With Thymic Carcinoma

Phase NA Completed

Thymoma

NCT06186726 2025-06-13

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Phase 2 Recruiting

Thymoma

NCT05667948 2025-05-22

Molecular Analysis and Treatment Options of Thymic Malignancies

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT06545409 2025-03-25

SPRATS

Phase NA Recruiting

Thymoma

NCT05255965 2025-01-16

IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

Thymoma

NCT06730308 2024-12-12

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Phase 2 Recruiting

Thymoma

NCT06692062 2024-11-18

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

Phase NA Recruiting

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT03583086 2024-10-08

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Phase 1/2 Completed

88 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT05214612 2024-07-31

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

Myasthenia Gravis, Nervous System Diseases, Thymoma, Thymus Hyperplasia, Autoimmune Diseases of the Nervous System, Neuromuscular Junction Diseases

NCT04072393 2024-07-12

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Phase NA Terminated

BreastGastrointestinalLymphoidSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Lung Neoplasms, Lymphoma, Non-Hodgkin, Sarcoma, Thymoma

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT06402708 2024-05-10

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

Thymoma

NCT04925947 2024-04-16

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Phase 2 Terminated

4 enrolled 10 charts

Thymoma

NCT06301945 2024-03-27

INTHYM

Thymic epithelial tumor, Thymoma

NCT06029621 2024-02-29

Robot-assisted vs VATS for Thymoma

Phase NA Recruiting

Thymoma

NCT02633553 2023-12-08

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Phase NA Recruiting

Thymoma

NCT02633514 2023-12-05

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Phase 3 Recruiting

Thymoma

NCT05455840 2023-10-31

A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease

Phase NA Unknown

Myasthenia Gravis, Thymoma

NCT04662645 2023-10-26

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Phase NA Completed

Lung Neoplasms, Thymoma

NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

Phase EARLY_PHASE1 Unknown

Thymoma

NCT06019468 2023-09-06

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Phase 2 Unknown

Thymoma

NCT06010277 2023-08-24

FLEX

Phase 4 Unknown

Other solid neoplasmThoracic

Mesothelioma, Thymoma

NCT05816694 2023-04-18

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

Phase 2 Not yet recruiting

Thymoma

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts

Thymoma

NCT04162691 2023-01-13

Single Cell Sequencing Analysis of Thymoma

Thymoma

NCT01272817 2022-11-23

Mini-allo

Phase NA Completed

BreastClassical hematologyDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Anemia, Aplastic, Breast Neoplasms, Carcinoma, Renal Cell, Hemoglobinuria, Paroxysmal, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Sarcoma, Thymoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05001113 2022-09-19

Surgery for Masaoka-Koga I-II Thymoma

Phase NA Completed

Thymoma

NCT02049047 2022-09-10

ONC-2010-001

Phase 2 Completed

Thymoma

NCT02307500 2022-09-10

RESOUND

Phase 2 Completed

DermatologicGastrointestinalGynecologicSarcomaThoracic

Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Thymoma

NCT04371458 2022-07-25

Thymectomy With and Without Povidone-iodine Pleural Lavage in Stage IVA Thymic Malignancies

Phase 1/2 Withdrawn

Thymoma

NCT03023319 2022-06-14

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Phase 1 Completed

GenitourinaryGynecologicOther solid neoplasmThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Mesothelioma, Ovarian Neoplasms, Thymoma, Thymus Neoplasms

NCT05407649 2022-06-07

Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours

Phase 2 Unknown

Thymoma

NCT05262582 2022-05-24

RATS

Phase NA Unknown

Myasthenia Gravis, Thymoma

NCT02220855 2022-04-11

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

Phase 2 Completed

14 enrolled 14 charts

Thymoma

NCT03663764 2021-12-10

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Phase 2 Unknown

Thymoma

NCT03449173 2021-06-09

Style

Phase 2 Unknown

Thymoma

NCT03613272 2021-05-07

The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum

Phase NA Unknown

Mediastinal Neoplasms, Myasthenia Gravis, Thymoma